4//SEC Filing
HighCape Partners QP II, L.P. 4
Accession 0001415889-22-013047
CIK 0001708527other
Filed
Dec 27, 7:00 PM ET
Accepted
Dec 28, 3:55 PM ET
Size
11.8 KB
Accession
0001415889-22-013047
Insider Transaction Report
Form 4
HighCape Partners GP II, LLC
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-12-22+17,533→ 17,533 total(indirect: See footnote)Exercise: $3.80Exp: 2032-12-21→ Class A Common Stock (17,533 underlying)
HighCape Partners GP II, L.P.
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-12-22+17,533→ 17,533 total(indirect: See footnote)Exercise: $3.80Exp: 2032-12-21→ Class A Common Stock (17,533 underlying)
HighCape Partners QP II, L.P.
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-12-22+17,533→ 17,533 total(indirect: See footnote)Exercise: $3.80Exp: 2032-12-21→ Class A Common Stock (17,533 underlying)
HighCape Partners II, L.P.
10% Owner
Transactions
- Award
Stock Option (Right to Buy)
2022-12-22+17,533→ 17,533 total(indirect: See footnote)Exercise: $3.80Exp: 2032-12-21→ Class A Common Stock (17,533 underlying)
Footnotes (2)
- [F1]This option vests in full and shall be fully exercisable on June 20, 2023, subject to Mr. Rakin's continuing in service on the Issuer's board of directors through the vesting date.
- [F2]Granted to Kevin L. Rakin as non-employee member of the Issuer's board of directors.
Documents
Issuer
AZIYO BIOLOGICS, INC.
CIK 0001708527
Entity typeother
IncorporatedDE
Related Parties
1- filerCIK 0001770972
Filing Metadata
- Form type
- 4
- Filed
- Dec 27, 7:00 PM ET
- Accepted
- Dec 28, 3:55 PM ET
- Size
- 11.8 KB